Peptide-based immunotherapy in lupus: Where are we now?
Related Posts
Haile K, Mungarwadi M, Ibrahim NA, Vaishnav A, Carrol S, Pandya N, Yarandi H, Sankari A, Martin JL, Badr MS. Using expanded diagnostic criteria mitigates[...]
Su H, Fuentes AL, Chen H, Malhotra A, Gallo LC, Song Y, Moore RC, Kamdar BB. The Financial Impact of Post Intensive Care Syndrome. Crit[...]
Seligman B, Wysham KD, Shahoumian T, Orkaby AR, Goetz MB, Osborne TF, Smith VA, Maciejewski ML, Hynes DM, Boyko EJ, Ioannou GN. Change in frailty[...]